FORT COLLINS, Colo., Oct. 23, 2024 /PRNewswire/ — PhotonPharma Inc., a leader in the development of autologous cancer immunotherapies with clearance from FDA to conduct a first-in-human clinical study in women with stage III/IV ovarian cancer with the investigational autologous vaccine,…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.